Gary E. Raskob
Impact in
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac Arrhythmias and Treatments
Papers in
-
- Venous Thromboembolism Diagnosis and Management 36
-
- Atrial Fibrillation Management and Outcomes 23
- Acute Myocardial Infarction Research 5
- Cardiac Arrhythmias and Treatments 4
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Giancarlo Agnelli (12 shared papers)Jeffrey I. Weitz (23 shared papers)Harry R. Büller (25 shared papers)Alexander Gallus (17 shared papers)Martin H. Prins (7 shared papers)Annelise Segers (17 shared papers)Harry R. Büller (3 shared papers)Raphael Pak (4 shared papers)
- Journals
- Thrombosis and Haemostasis (10 papers)Journal of Thrombosis and Haemostasis (7 papers)New England Journal of Medicine (7 papers)Blood (3 papers)The Lancet (3 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Gary E. Raskob
51 papers receiving 7.3k citations
Gary E. Raskob's Hit Papers
Peers
Comparison fields: 5 of 102
- Internal Medicine 5.1k
- Cardiology and Cardiovascular Medicine 3.9k
- Hematology 1.3k
- Emergency Medical Services 607
- Genetics 663
Countries citing papers authored by Gary E. Raskob
This map shows the geographic impact of Gary E. Raskob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Raskob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Raskob more than expected).
Fields of papers citing papers by Gary E. Raskob
This network shows the impact of papers produced by Gary E. Raskob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Raskob. The network helps show where Gary E. Raskob may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Raskob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral Apixaban for the Treatment of Acute Venous Thromboembolism Hit paper breakdown → | 2013 | 1722 |
| 2 | Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Hit paper breakdown → | 2017 | 1113 |
| 3 | Antithrombotic Therapy for Venous Thromboembolic Disease Hit paper breakdown → | 2004 | 961 |
| 4 | Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Hit paper breakdown → | 2010 | 609 |
| 5 | Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery Hit paper breakdown → | 2008 | 508 |
| 6 | Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Hit paper breakdown → | 2014 | 472 |
| 7 | 2008 | 272 | |
| 8 | 1994 | 212 | |
| 9 | Abelacimab for Prevention of Venous Thromboembolism Hit paper breakdown → | 2021 | 192 |
| 10 | Milvexian for the Prevention of Venous Thromboembolism Hit paper breakdown → | 2021 | 177 |
| 11 | 2015 | 156 | |
| 12 | 2001 | 146 | |
| 13 | 2010 | 127 | |
| 14 | 2016 | 120 | |
| 15 | 2003 | 97 | |
| 16 | 2009 | 87 | |
| 17 | The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. | 1997 | 86 |
| 18 | 2013 | 66 | |
| 19 | 2007 | 51 | |
| 20 | 2016 | 47 |
About Gary E. Raskob
Gary E. Raskob is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Surgery, Hematology and Genetics, having authored 53 papers that have together received 7.6k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (36 papers), Atrial Fibrillation Management and Outcomes (23 papers), Acute Myocardial Infarction Research (5 papers), Cardiac Arrhythmias and Treatments (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Case Reports on Hematomas (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Blood Pressure and Hypertension Studies (3 papers). The work is most often cited by research in Internal Medicine (5.1k citations), Cardiology and Cardiovascular Medicine (3.9k citations), Hematology (1.3k citations), Emergency Medical Services (607 citations) and Genetics (663 citations). Gary E. Raskob has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Giancarlo Agnelli, Jeffrey I. Weitz, Harry R. Büller, Alexander Gallus, Martin H. Prins, Annelise Segers, Harry R. Büller, Raphael Pak, Madelyn Curto and Russel Hull. Their work appears in journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, New England Journal of Medicine, Blood and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.